Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-014521
Filing Date
2024-11-06
Accepted
2024-11-06 07:00:40
Documents
74
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q elev-20240930x10q.htm   iXBRL 10-Q 2285872
2 EX-31.1 elev-20240930xex31d1.htm EX-31.1 15583
3 EX-31.2 elev-20240930xex31d2.htm EX-31.2 15555
4 EX-32 elev-20240930xex32.htm EX-32 8185
  Complete submission text file 0001558370-24-014521.txt   8486501

Data Files

Seq Description Document Type Size
5 EX-101.SCH elev-20240930.xsd EX-101.SCH 50577
6 EX-101.CAL elev-20240930_cal.xml EX-101.CAL 39797
7 EX-101.DEF elev-20240930_def.xml EX-101.DEF 220087
8 EX-101.LAB elev-20240930_lab.xml EX-101.LAB 478108
9 EX-101.PRE elev-20240930_pre.xml EX-101.PRE 376083
77 EXTRACTED XBRL INSTANCE DOCUMENT elev-20240930x10q_htm.xml XML 1409618
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

EIN.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40523 | Film No.: 241429185
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)